Abstract:Systemic inflammatory response syndrome (SIRS) is a severe inflammatory response that can lead to organ dysfunction and death. Modulating the gut microbiome is a promising therapeutic approach for managing SIRS. This study assesses the therapeutic potential of the Xuanfei Baidu (XFBD) formula in treating SIRS. The results showed that XFBD administration effectively reduced mortality rates and inflammation in SIRS mice. Using 16S rRNA sequencing and fecal microbiota transplantation (FMT), we substantiated that the therapeutic effects of XFBD are partly attributed to gut microbiota modulation. We conducted in vitro experiments to accurately assess the gut microbiome remodeling effects of 51 compounds isolated from XFBD. These compounds exhibited varying abilities to induce a microbial structure that closely resembles that of the healthy control group. By quantifying their impact on microbial structure and clustering their regulatory patterns, we devised multiple gut microbiome remodeling compound (GMRC) cocktails. GMRC cocktail C, comprising aucubin, gentiopicroside, syringic acid, gallic acid, p-hydroxybenzaldehyde, para-hydroxybenzoic acid, and isoimperatorin, demonstrated superior efficacy in treating SIRS compared to a single compound or to other cocktails. Finally, in vitro experiments showcased that GMRC cocktail C effectively rebalanced bacteria composition in SIRS patients. This study underscores XFBD's therapeutic potential in SIRS and highlights the importance of innovative treatment approaches for this disease by targeting the gut microbiota.IMPORTANCEDeveloping effective treatment strategies for systemic inflammatory response syndrome (SIRS) is crucial due to its severe and often life-threatening nature. While traditional treatments like dexamethasone have shown efficacy, they also come with significant side effects and limitations. This study makes significant strides by demonstrating that the Xuanfei Baidu (XFBD) formula can substantially reduce mortality rates and inflammation in SIRS mice through effective modulation of the gut microbiota. By quantitatively assessing the impact of 51 compounds derived from XFBD on the gut microbiome, we developed a potent gut microbiome remodeling compound cocktail. This cocktail outperformed individual compounds and other mixtures in efficacy against SIRS. These findings highlight the potential of XFBD as a therapeutic solution for SIRS and underscore the critical role of innovative strategies targeting the gut microbiota in addressing this severe inflammatory condition.

Herbal formula BaWeiBaiDuSan alleviates polymicrobial sepsis-induced liver injury via increasing the gut microbiota Lactobacillus johnsonii and regulating macrophage anti-inflammatory activity in mice

Lactobacillus Rhamnosus Gg Treatment Improves Intestinal Permeability And Modulates Microbiota Dysbiosis In An Experimental Model Of Sepsis

Targeted discovery of gut microbiome-remodeling compounds for the treatment of systemic inflammatory response syndrome

Wangshi Baochi Pills Alleviate Alcoholic Liver Disease by Regulating the Gut Microbiota Composition in a Mouse Model

Baicalin Improves Survival in A Murine Model of Polymicrobial Sepsis Via Suppressing Inflammatory Response and Lymphocyte Apoptosis

Lactobacillus Johnsonii 6084 Alleviated Sepsis‐induced Organ Injury by Modulating Gut Microbiota

Liu-Shen-Wan, A Traditional Chinese Medicine, Improves Survival in Sepsis Induced by Cecal Ligation and Puncture Via Reducing Tnf-Alpha Levels, Mda Content and Enhancing Macrophage Phagocytosis

Sini Decoction Ameliorates Interrelated Lung Injury in Septic Mice by Modulating the Composition of Gut Microbiota.

Maintaining immune homeostasis with Coptis Chinensis water extract to mitigate sepsis severity via modulating gut microbiome and metabolism

The Chinese medicine babaodan suppresses LPS-induced sepsis by inhibiting NLRP3-mediated inflammasome activation

Silibinin protects against sepsis and septic myocardial injury in an NR1H3-dependent pathway

Protection of Baicalin Against Lipopolysaccharide Induced Liver and Kidney Injuries Based on 1H NMR Metabolomic Profiling.

Deciphering the Mechanism of Huang-Lian-Jie-Du-Decoction on the Treatment of Sepsis by Formula Decomposition and Metabolomics: Enhancement of Cholinergic Pathways and Inhibition of HMGB-1/TLR4/NF-κB Signaling.

Lobetyolin protects mice against LPS-induced sepsis by downregulating the production of inflammatory cytokines in macrophage

Baicalein protects against polymicrobial sepsis-induced liver injury via inhibition of inflammation and apoptosis in mice.

Buyang huanwu decoction (BYHWD) alleviates sepsis-induced myocardial injury by suppressing local immune cell infiltration and skewing M2-macrophage polarization

Lacticaseibacillus Rhamnosus TR08 Alleviated Intestinal Injury and Modulated Microbiota Dysbiosis in Septic Mice

Xuebijing Injection Alleviates Pam3CSK4-Induced Inflammatory Response and Protects Mice From Sepsis Caused by Methicillin-Resistant Staphylococcus aureus

The Protective Effect of Broccoli Seed Extract against Lipopolysaccharide-Induced Acute Liver Injury via Gut Microbiota Modulation and Sulforaphane Production in Mice

Pulmonary , gastrointestinal and urogenital pharmacology Baicalein protects against polymicrobial sepsis-induced liver injury via inhibition of in fl ammation and apoptosis in mice

Beneficial effects of silibinin on serum lipids, bile acids, and gut microbiota in methionine-choline-deficient diet-induced mice